Specifically, we found that MLH1-deficient cell lines exhibit reduced levels of SPTAN1 and have impaired migratory ability [7], initially suggesting that loss of SPTAN1 may be partly responsible for the reduced metastatic efficiency of MMR-deficient tumour cells. The gene discussed is SPTAN1; the disease is neoplasm.